STRATEC SE (SBS.DE) Stock Price, Forecast & Analysis
Europe - Frankfurt Stock Exchange - FRA:SBS - DE000STRA555 - Common Stock
SBS.DE Key Statistics, Chart & Performance
The current stock price of SBS.DE is 24.4 EUR. In the past month the price increased by 6.55%. In the past year, price decreased by -16.01%.
SBS.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 17.6 | 109.18B | ||
| 1MDT.MI | MEDTRONIC PLC | 17.01 | 105.52B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 19.46 | 52.46B | ||
| 1SHL.MI | SIEMENS HEALTHINEERS AG | 19.43 | 52.37B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 17.18 | 24.49B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 17.17 | 24.47B | ||
| BIM.PA | BIOMERIEUX | 29.25 | 13.36B | ||
| OBCK.DE | OTTOBOCK SE & CO KGAA | 150 | 4.51B | ||
| DIA.MI | DIASORIN SPA | 21.93 | 4.06B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 25.63 | 3.69B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 11.66 | 1.41B | ||
| ELN.MI | EL.EN. SPA | 22.86 | 1.18B |
Related stock screener links
About SBS.DE
Company Profile
STRATEC SE engages in the design and manufacture of automated analyzer systems in the fields of clinical diagnostic and biotechnology. The company is headquartered in Birkenfeld, Baden-Wuerttemberg and currently employs 1,450 full-time employees. The firm is engaged in development and manufacture of analyzer systems, and it is also performing and managing administrative and organizational tasks for laboratory markets. Stratec is providing automation solutions and instrumentation of biochemical processes using hardware and software for in-vitro diagnostics and life science companies. The company also developing and integrating instrumentation, complex consumables and software by covering virtually the entire value chain for specification, design, manufacture and approval of complex analyzer system solutions.
Company Info
STRATEC SE
Gewerbestr. 37
BIRKENFELD BADEN-WUERTTEMBERG DE
Employees: 1450
Phone: 49708279160
STRATEC SE / SBS.DE FAQ
Can you describe the business of STRATEC SE?
STRATEC SE engages in the design and manufacture of automated analyzer systems in the fields of clinical diagnostic and biotechnology. The company is headquartered in Birkenfeld, Baden-Wuerttemberg and currently employs 1,450 full-time employees. The firm is engaged in development and manufacture of analyzer systems, and it is also performing and managing administrative and organizational tasks for laboratory markets. Stratec is providing automation solutions and instrumentation of biochemical processes using hardware and software for in-vitro diagnostics and life science companies. The company also developing and integrating instrumentation, complex consumables and software by covering virtually the entire value chain for specification, design, manufacture and approval of complex analyzer system solutions.
What is the current price of SBS stock?
The current stock price of SBS.DE is 24.4 EUR. The price increased by 8.44% in the last trading session.
Does STRATEC SE pay dividends?
STRATEC SE (SBS.DE) has a dividend yield of 2.67%. The yearly dividend amount is currently 0.55.
How is the ChartMill rating for STRATEC SE?
SBS.DE has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
What is the analyst forecast for SBS.DE stock?
12 analysts have analysed SBS.DE and the average price target is 34.58 EUR. This implies a price increase of 41.71% is expected in the next year compared to the current price of 24.4.
What is the Price/Earnings (PE) ratio of STRATEC SE (SBS.DE)?
The PE ratio for STRATEC SE (SBS.DE) is 18.48. This is based on the reported non-GAAP earnings per share of 1.32 and the current share price of 24.4 EUR.
Can you provide the number of employees for STRATEC SE?
STRATEC SE (SBS.DE) currently has 1450 employees.
SBS.DE Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to SBS.DE. When comparing the yearly performance of all stocks, SBS.DE is a bad performer in the overall market: 89.56% of all stocks are doing better.
SBS.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to SBS.DE. Both the profitability and the financial health of SBS.DE get a neutral evaluation. Nothing too spectacular is happening here.
SBS.DE Financial Highlights
Over the last trailing twelve months SBS.DE reported a non-GAAP Earnings per Share(EPS) of 1.32. The EPS increased by 4.26% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 6.22% | ||
| ROA | 3.72% | ||
| ROE | 6.67% | ||
| Debt/Equity | 0.49 |
SBS.DE Forecast & Estimates
12 analysts have analysed SBS.DE and the average price target is 34.58 EUR. This implies a price increase of 41.71% is expected in the next year compared to the current price of 24.4.
For the next year, analysts expect an EPS growth of -10.4% and a revenue growth 1.41% for SBS.DE